BridgeBio has substantially advanced its progress of a new therapy for amyloid heart disease, utilizing Attruby. Early clinical results indicates potential improvements for patients diagnosed by the serious illness. https://bridgebio805630.azzablog.com/42574412/bridgebio-progresses-attr-cm-therapy-through-the-therapy